How many studies have been conducted on Oxyntomodulin?

BiohacksAI has indexed 300 PubMed studies on Oxyntomodulin, including 17 randomized controlled trials (RCTs). 26% of studies involve human subjects.

What are the main research areas for Oxyntomodulin?

The primary research domains for Oxyntomodulin are 🔥 Metabolic, 🦠 Gut & Microbiome, 🧬 Hormones. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Oxyntomodulin

A 37-amino acid peptide derived from the C-terminal of GLICENTIN. It is mainly produced by the INTESTINAL L CELLS. Oxyntomodulin can reduce digestive secretions, delay gastric emptying, and reduced food intake.

300+ PubMed studies analyzed · 17 RCTs · Evidence Score: 48.3

Research Domains

Oxyntomodulin has been studied across 17 research domains including 🔥 Metabolic, 🦠 Gut & Microbiome, 🧬 Hormones, ⚡ Energy & Fatigue, 🫁 Liver & Detox. The primary research focus is 🔥 Metabolic with 58% of studies addressing this area.

Loading evidence profile...

This evidence profile for Oxyntomodulin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.